ResultsIQ › Latest results › Sudeep Pharma Limited
Sudeep Pharma Limited Q4 FY26 results deck summary
NSE: SUDEEPPHRM · BSE: 544619
Results deck of 21 May 2026, summarised by AI from the filing.
Sudeep Pharma reports highest-ever FY26 revenue of ₹642.3 cr (+28%) and PAT of ₹174.3 cr (+26%), with Battery Materials Phase 1 targeted for March 2027.
Key takeaways
- Battery Materials target Target 100,000 MT battery-grade iron phosphate capacity by 2030; Phase 1 of 25,000 MT completion by March 2027
- Growth drivers NSS integration, battery materials orders, geographic expansion in Peru, US and Europe
- Raw material risk Sharp increases in phosphoric acid and sulphuric acid prices; price revisions implemented with customers
Sudeep Pharma Limited Q1 FY27 results
As filed: Revenue ₹158 cr, EBITDA ₹54.9 cr, PAT ₹40.6 cr, EBITDA margin 34.7%.
Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹158 cr). Scored once a year-earlier consolidated quarter exists.
Earlier results and the share price after them
- Q4 FY26: Revenue ₹182 cr, EBITDA ₹62.6 cr, PAT ₹48.5 cr, EBITDA margin 34.3%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹182 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +26.2% in 29 days (Nifty 500: +2.4%).
- Q3 FY26: Revenue ₹172 cr, EBITDA ₹60.0 cr, PAT ₹47.7 cr, EBITDA margin 34.8%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹172 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −8.7% in 28 days (Nifty 500: −4.1%).
- Q2 FY26: Revenue ₹163 cr, EBITDA ₹56.0 cr, PAT ₹47.0 cr, EBITDA margin 34.4%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹163 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −14.7% in 28 days (Nifty 500: −0.8%).
Past price moves after results do not indicate future moves. Not a recommendation.
Sudeep Pharma Limited earnings call, investor presentation and press release summaries
- Q1 FY27: Earnings call (5 Aug 2026), Results deck (4 Aug 2026), Results deck (4 Aug 2026), Results deck (4 Aug 2026)
- Q4 FY26: Earnings call (22 May 2026), Results deck (21 May 2026)
- Q3 FY26: Earnings call (9 Feb 2026), Results deck (7 Feb 2026)
- Q2 FY26: Earnings call (22 Dec 2025), Results deck (21 Dec 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.